Social Networks and Pharmacovigilance: What Will Change?

Instructor: Marco Anelli
Product ID: 704690
  • Duration: 90 Min
This training program will examine the different types of social networks (Facebook, Twitter, etc.) and help identify similarities, differences, and challenges for pharmacovigilance (PV) professionals. It will also analyze social networks and the new approach to benefit/risk ratio.
Purchase option for this webinar is currently unavailable. Please contact our Customer Care for more info.

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

Why Should You Attend:

A key benefit of social media is that it can be mined to generate hypotheses related to drug efficacy and safety. These data may provide an early warning about potentially serious but rare adverse events (AEs). However, social media also presents technical and regulatory challenges as pharmaceutical companies are required to report to regulatory authorities all AEs of which they become aware that contain the 4 required elements for reporting.

However, the emergence of social media and its use by biopharmaceutical manufacturers and their stakeholders present promising new opportunities along with challenges for pharmacovigilance (PV) professionals and procedures and processes will probably need to be reviewed and updated

Learning Objectives:

  • To examine the different types of social networks (Facebook, Twitter, etc.) and identify similarities and differences.
  • To understand the shift in the benefit/risk ratio determination and data collection caused by the possible use of these new media.
  • To understand the present and future approach to addressing the problem.
  • To evaluate the possible impact on pharmacovigilance/signal detection procedures and the need for corrective actions.

Areas Covered in the Webinar:

  • Social networks: Overview and examples
  • The existing guidelines: A critical appraisal
  • Social networks and the new approach to benefit/risk ratio
  • Possible impact on procedures/processes
  • The role of artificial intelligence
  • Possible evolutions and outcomes

Who Will Benefit:

  • PV Stakeholders
    • General Managers
    • Policy Makers
    • Knowledge Management Specialists
    • PV Executives
    • Regulatory Affairs Executives
  • QPPVs
  • IT Professionals

Instructor Profile:

Since January 2016, Marco Anelli serves as the head of pharmacovigilance and medical affairs advisory services at Product Life Group, an international consultancy company. Previously, he has been R&D director at Keypharma, an Italy-based ProductLife Group company, and was responsible for the coordination of all clinical and preclinical aspects of projects run internally and on behalf of clients.

Drawing on a career in the pharmaceutical industry that spans 25 years, Mr. Anelli provides expert oversight on a wide range of R&D and medical affairs related activities. He has participated in and coordinated all stages of drug development -- from formulation to Phase I-IV and pharmacovigilance. In addition, he is a qualified QPPV and has prepared and overseen more than 200 non-clinical and clinical overviews and summaries.

In recent years, has worked extensively in the fields of pharmacoeconomics and health technology assessment. He has a medical degree from Milan University, specializations in medical statistics and clinical pharmacology from Pavia University and an international master’s degree in health economics and pharmacoeconomics from Pompeu Fabra University in Barcelona.

Follow us :
Lifecycle Management of Analytical Methods and Procedures

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed